The Beauty Health Company reported third quarter 2025 net sales of $70.7 million, down from $78.8 million in the same period last year. Gross profit for the quarter was $45.6 million compared to $40.6 million a year ago. Adjusted EBITDA for the quarter reached $8.9 million, exceeding the company's guidance range. For the first nine months of 2025, net sales totaled $218.4 million, a decrease from $250.8 million in the prior year. The company's recurring consumables business continued to show resilience and profitability, while device sales remained under pressure. Cash, cash equivalents, and restricted cash at the end of the first nine months stood at $370.1 million, down from $523.0 million at the same point last year.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Beauty Health Company published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9570647-en) on November 06, 2025, and is solely responsible for the information contained therein.